Sign in →

Test Code LAB3500 Thyroglobulin, Tumor Marker, Serum

Useful For

Follow-up of patients with differentiated thyroid cancers after thyroidectomy and radioactive iodine ablation

Reporting Name

Thyroglobulin, Tumor Marker

Specimen Type

Serum Red


Ordering Guidance


For accurate analysis of patients who are known to be thyroglobulin antibody positive, order TGMS / Thyroglobulin Mass Spectrometry, Serum.



Specimen Required


Patient Preparation: For 12 hours before specimen collection, patient should not take multivitamins or dietary supplements (eg, hair, skin, and nail supplements) containing biotin (vitamin B7).

Supplies: Sarstedt Aliquot Tube, 5 mL (T914)

Collection Container/Tube:

Preferred: Red top

Acceptable: None (serum gel/SST are not acceptable)

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL

Collection Instructions: Centrifuge and aliquot serum into a plastic vial.


Specimen Minimum Volume

0.5 mL

Specimen Stability Information

Specimen Type Temperature Time
Serum Red Refrigerated (preferred) 7 days
  Frozen  30 days
  Ambient  7 days

Reject Due To

Gross hemolysis Reject
Gross lipemia OK
Gross icterus Reject

Reference Values

Thyroglobulin Tumor Marker

≤33 ng/mL

 

Thyroglobulin Antibody:

<1.8 IU/mL

Reference values apply to all ages.

Cautions

The test is most sensitive for detection of thyroid cancer recurrence when patients are off thyroid replacement long enough to have an elevated thyrotropin (TSH) prior to collecting the specimen. This test also can be used to follow patients with normal TSH; however, thyroglobulin (Tg) values from specimens with high TSH should not be compared with values with normal TSH, because TSH stimulation changes the baseline determinations.

 

Thyroglobulin autoantibodies (TgAb) may interfere with the measurement of Tg. All specimens are prescreened for TgAb, and a comment appended to the report if they are present. Undetectable levels of Tg should be interpreted with caution if TgAb are present. A Tg antibody result of less than 1.8 IU/mL is unlikely to cause clinically significant Tg assay interference. It is recommended that the Tg result be reviewed for concordance with clinical presentation.

 

In rare cases, some individuals can develop antibodies to mouse or other animal antibodies (often referred to as human anti-mouse antibodies [HAMA] or heterophile antibodies), which may cause interference in some immunoassays. Caution should be used in interpretation of results, and the laboratory should be alerted if the result does not correlate with the clinical presentation.

 

Specimens with Tg concentrations greater than 250,000 ng/mL may "hook" and appear to have markedly lower levels.

 

Thyroglobulin and TgAb values determined by different methodologies might vary significantly and cannot be directly compared with one another. Some patients might be antibody-positive by some methods and antibody-negative by others. Comparing values from different methods might lead to erroneous clinical interpretation.

Day(s) Performed

Monday through Saturday

Report Available

1 to 3 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information

84432

86800

LOINC Code Information

Test ID Test Order Name Order LOINC Value
HTG2 Thyroglobulin, Tumor Marker 57780-9

 

Result ID Test Result Name Result LOINC Value
TGAB2 Thyroglobulin Antibody, S 56536-6
HTGN2 Thyroglobulin, Tumor Marker, S 3013-0
HTG2I Thyroglobulin Interpretation 69053-7

NY State Approved

Yes

Method Name

Immunoenzymatic Assay

Forms

If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:

-General Request (T239)

-Oncology Test Request (T729)

-Renal Diagnostics Test Request (T830)

Secondary ID

62800